Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 1,105 | 653 | 968 | 1,269 | 3,919 |
| Gross Profit | 1,105 | 653 | 968 | 1,269 | 3,919 |
| Operating Expenses | 49,809 | 41,984 | 39,351 | 35,237 | 36,015 |
| Operating Income | -48,704 | -41,331 | -38,383 | -33,968 | -32,096 |
| Other Income | 7,828 | 2,567 | 1,108 | 321 | 30 |
| Pre-tax Income | -40,876 | -38,764 | -37,275 | -33,647 | -32,066 |
| Net Income Continuous | -40,876 | -38,764 | -37,275 | -33,647 | -32,066 |
| Net Income | $-40,876 | $-38,764 | $-37,275 | $-33,647 | $-32,066 |
| EPS Basic Total Ops | -0.86 | -0.91 | -0.90 | -0.86 | -0.82 |
| EPS Basic Continuous Ops | -0.86 | -0.91 | -0.90 | -0.86 | -0.82 |
| EPS Diluted Total Ops | -0.86 | -0.91 | -0.90 | -0.86 | -0.82 |
| EPS Diluted Continuous Ops | -0.86 | -0.91 | -0.90 | -0.86 | -0.82 |
| EPS Diluted Before Non-Recurring Items | -0.86 | -0.90 | -0.90 | -0.86 | -0.82 |
| EBITDA(a) | $-53,467 | $-42,759 | $-39,098 | $-33,965 | $-32,009 |